CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Pharmicell Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Pharmicell Co Ltd
12F, Cheongho Bldg.
3-2, Nonhyeon-Dong, Gangnam-Gu
Phone: +82 234960114p:+82 234960114 SEOUL, 06017  South Korea Ticker: 005690005690
Business Summary
Pharmicell Co Ltd is a Korea-based company primarily engaged in the biopharmaceutical business. The Company operates through two business segments. The Biochemical Business segment primarily manufactures and sells pharmaceutical intermediates, gene therapy and diagnostic kits, phosphorus-based flame retardants and other industrial chemicals. The Biomedical Business segment primarily develops and sells stem cell therapies, cosmetics containing stem cell culture media and acute myocardial infarction treatments as well as cell processing and contract testing services provision. The Company also provides contract manufacturing development and quality control services.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202512/31/2024Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products
2836 Biological products, except diagnostic substances
2844 Perfumes, cosmetics, and other toilet preparations
8099 Health and allied services, not elsewhere classified
7389 Business services, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman, Chief Executive Officer Hyeon SuKim 61 1/1/2024 8/19/2009
Vice President Seong NyeonKim 58 3/25/2023 3/25/2023
Managing Director Gil SuJung 49 1/1/2024 1/1/2021
7 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
PHARMICELL CO LTD CHEMICAL BUSINES 249 GONGDAN-RO ULSAN KR

Business Names
Business Name
005690
FCB TWELVE
ID Biochem, Inc.
PHARMICELL CO LTD CHEMICAL BUSINES
Roi Corporation
Yuhwa Corporation

General Information
Number of Employees: 175 (As of 9/30/2025)
Outstanding Shares: 60,004,014 (As of 9/30/2025)
Shareholders: 56,582
Stock Exchange: KRX
Fax Number: +82 234960159


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, December 13, 2025